The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors.

The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors.

Leuk Lymphoma. 2019 Feb 18;:1-3

Authors: Copeland AC, Foster MC, Muluneh B, Xenakis JG, Ivanova A, Frankfurt O, Clayton M, Black A, Rapchak B, Wehbie RS

PMID: 30773105 [PubMed - as supplied by publisher]